A recent case report examined the adverse effects of alemtuzumab in a patient with relapsing remitting multiple sclerosis.
Researchers compared the efficacy of plasma exchange vs no plasma exchange, in terms of end-stage kidney disease or death, in patients with severe ANCA-associated vasculitis.
Researchers reported on the outcomes of treatment-refractory, corticosteroid-dependent patients with eosinophilic granulomatosis with polyangiitis with severe asthma.
In this study, researchers used immunophenotyping to explore the biomarkers associated with clinical characteristics in large vessel vasculitis.
The American College of Rheumatology and the European League Against Rheumatism developed and validated an international set of classification criteria for IgG4-related disease.
Researchers suggest that temporal ultrasound may be an appealing choice for monitoring disease activity in patients with cranial giant cell arteritis treated with tocilizumab.
Researchers studied the risk factors for relapse, including prednisolone clearance and glucocorticoid-induced transcript 1 promoter polymorphism (rs37972), in patients with giant cell arteritis.
From 1999 to 2017, there was a decrease in mortality among individuals with antineutrophil cytoplasmic autoantibody-associated vasculitides in the United States.
Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are rare diseases that are generally specific to the lungs, kidneys and upper airways.
The study compared general and giant cell arteritis-specific characteristics in patients with and without visual symptoms, and examined the role of diagnostic delay in patients with giant cell arteritis experiencing current visual symptoms.